Estrella Immunopharma Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Cheng Liu
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 0.8% |
| Management average tenure | no data |
| Board average tenure | less than a year |
Recent management updates
CEO
Cheng Liu (57 yo)
no data
Tenure
Dr. Cheng Liu, PhD, is Founder of Eureka Therapeutics, Inc. and has been its Chief Executive Officer and President and Member of Board of Directors since May 2006. He is the Chief Executive Officer, Presid...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | no data | no data | 0.82% $ 352.1k | |
| Member of Advisory Board | no data | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | no data | no data | no data | |
| Independent Director | less than a year | no data | no data |
1.0yrs
Average Tenure
55.5yo
Average Age
Experienced Board: ESLA's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.